Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Biomaterials. 2010 May 21;31(24):6190–6200. doi: 10.1016/j.biomaterials.2010.04.036

Figure 7. Limitations in the maturation of human MSC-seeded nanofibrous constructs are not dependent on age or disease-status.

Figure 7

A) Tensile stiffness of healthy MSC constructs on day 63 normalized to unseeded control scaffolds (grey bar). GAG (B) and collagen (C) content of day 63 constructs. Dotted lines and gray regions represent the average and full range of response of OA MSCs, respectively. Cross-sections of day 63 Donor 5 MSC-seeded nanofibrous constructs stained for cell nuclei (D), GAG (E), and collagen (F). Scale: 500μm.

HHS Vulnerability Disclosure